GlassScriptPhysician profile
Zachary Simons
NPI 1730569476
$1,246.06
in general payments reported to CMS, 2019-2025
17 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $38.77 · 2023: $524 · 2024: $501 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,207.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $293.08 | 2022-2024 | Mounjaro, Zepbound, Trulicity |
| Amgen INC. | $211.43 | 2022-2024 | Otezla, Evenity, Prolia |
| Tandem Diabetes Care, INC. | $132.00 | 2023-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $110.70 | 2023-2025 | Dexcom G6 Transmitter |
| Amphastar Pharmaceuticals, INC. | $74.57 | 2023-2024 | Baqsimi |
| Insulet Corporation | $62.32 | 2024-2025 | Omnipod |
| Medtronic, INC. | $48.51 | 2023-2025 | Minimed 780g |
| Alvogen INC | $44.15 | 2023 | Teriparatide |
| Sanofi-Aventis U.S. LLC | $42.69 | 2024 | |
| Radius Health, INC. | $42.36 | 2023-2024 | Tymlos |
| Mannkind Corporation | $40.71 | 2024-2025 | |
| Novo Nordisk INC | $39.39 | 2023-2024 | Wegovy, Ozempic, Rybelsus |
| Beta Bionics, INC. | $34.45 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Ascendis Pharma Endocrinology INC | $23.75 | 2025 | Yorvipath |
| Sequel Med Tech, LLC | $17.39 | 2025 | Twiist |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15.49 | 2024 | Freestyle Libre 3 |
| Acella Pharmaceuticals, LLC | $13.07 | 2023 | NP Thyroid 60 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Simons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.